Internet OTC drug sales legal in Poland
The selling via the Internet of non-prescription drugs is legal, the Provincial Court in Warsaw, Poland, has ruled. The judgement overturns a previously-unfavorable decision by one of the country's provincial pharmaceutical inspectors and will benefit 100 Internet-based pharmacies. The court's verdict implemented European Union rules and a ruling of the European Court of Justice.
In other news, Miaxigra, a copycat version of USA-headquartered global drug behemoth Pfizer's Viagra (sildenafil citrate) is beginning to be sold in pharmacies in spite of a two-year legal battle with Polish drugmaker Polpharma. The local firm claims the active substance of Miaxigra was elaborated by a research team from Pharmaceutical Institute in Warsaw and sells it at a discount compared with the US firm's branded product.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze